Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Kolling Institute Tumour Bank
Events, News and Seminars
Kolling NEWS
Posted on: 05 February, 2024
We’re kicking off the year with plenty of encouraging research news. Read on for details about new f..... Read more
Category: Newsletters, Research Excellence
Significant investment in our research announced
Posted on: 13 September, 2023
A large collection of research projects will get off the ground following generous funding through t..... Read more
Category: Awards, Funding support, Research Excellence
Crucial funds strengthening our research expertise
Posted on: 12 September, 2023
A group of young researchers will have the chance to broaden their skills and establish new collabor..... Read more
Category: Funding support, Research Excellence